Status:
COMPLETED
Effects of a Common Cold Treatment on Cognitive Function
Lead Sponsor:
GlaxoSmithKline
Conditions:
Common Cold
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A reduction in alertness and lower levels of performance are commonly associated with the common cold. Paracetamol has been shown to be more effective than placebo in treating symptoms associated with...
Eligibility Criteria
Inclusion
- Present with symptoms of the common cold of no more than 96 hours duration
- Score of "2" or more on a self-rating for malaise and at least 4 other cold symptoms
Exclusion
- Pregnancy or lactation
- Hypersensitivity to drugs
- Have taken caffeine in the last 12 hours or treated their cold
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01466348
Start Date
February 1 2011
End Date
April 1 2011
Last Update
November 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Common Cold Centre
Cardiff, Wales, United Kingdom